Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,704
Closed -$201K 333
2019
Q3
$201K Sell
2,704
-14
-0.5% -$1.13K 0.06% 348
2019
Q2
$231K Sell
2,718
-263
-9% -$21.1K 0.07% 312
2019
Q1
$256K Buy
+2,981
New +$243K 0.07% 309
2018
Q4
Sell
-4,541
Closed -$314K 391
2018
Q3
$314K Buy
4,541
+13
+0.3% +$892 0.04% 387
2018
Q2
$303K Buy
4,528
+41
+0.9% +$2.8K 0.04% 387
2018
Q1
$374K Buy
4,487
+47
+1% +$4.24K 0.06% 326
2017
Q4
$421K Buy
4,440
+44
+1% +$4.6K 0.06% 298
2017
Q3
$513K Buy
4,396
+204
+5% +$25.8K 0.08% 262
2017
Q2
$528K Sell
4,192
-105
-2% -$13.4K 0.09% 245
2017
Q1
$574K Buy
+4,297
New +$547K 0.1% 229

Other funds holding INCY

ClearArc Capital's INCY Position: Q4 2019 in Review

ClearArc Capital sold out of Incyte (INCY) in Q4 2019, closing a stake of 2,704 shares — an estimated $201K sold.

ClearArc Capital first reported a position in INCY in Q1 2017 and held it in 10 quarters. The position peaked at $574K in Q1 2017. 556 funds tracked by Wall St. Rank hold INCY as of Q4 2019.

  • ClearArc Capital reported no remaining Incyte position as of Q4 2019 after selling out during the quarter.
  • ClearArc Capital sold 2,704 Incyte shares in Q4 2019, an estimated $201K.
  • ClearArc Capital first reported a position in Incyte in Q1 2017 and held it in 10 quarters.
  • ClearArc Capital's Incyte position peaked at $574K in Q1 2017.
  • 556 funds tracked by Wall St. Rank held Incyte as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.